Jim Cramer Says Kimberly-Clark and Kenvue Merger “Will Produce Tremendous Returns”

Kimberly-Clark Corporation (NASDAQ:KMB) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com ...

Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America

Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy’ rating and $120 price objective from Bank of America ...
U.S. News & World Report

Kimberly-Clark Bets $40 Billion for Kenvue Despite Tylenol Controversy

(Reuters) -Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol maker struggles with weak sales, lawsuits and White House attacks ...
WBAL-TV

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Kenvue shareholders will receive $3.50 per share in ...

Here’s Why Kimberly-Clark (KMB) is an Undervalued Stocks to Buy Under $100

Kimberly-Clark Corporation (NASDAQ:KMB) trades at a discounted forward price to earnings ratio of 12.7, below the sector ...
Business Journal Daily

Kimberly-Clark’s Trumbull Plant Eyes Megasite Growth

Explore the future of Kimberly Clark with insights on the new facility's impact and potential for regional growth and ...

Is Kimberly-Clark Corporation (KMB) A Good Stock To Buy Now?

Is KMB a good stock to buy? We came across a bullish thesis on Kimberly-Clark Corporation on Investing Lawyer’s Substack. In ...
ABC7

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7B consumer brands deal

CHICAGO -- Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own ...